Richardson, P. G., & Raab, M. (2014). Final results for the 1703 phase 1b/2 study of Elotuzumab in combination with Lenalidomide and Dexamethasone in patients with relapsed/refractory multiple myeloma. Blood, 124(21), .
Chicago Style (17th ed.) CitationRichardson, Paul G., and Marc-Steffen Raab. "Final Results for the 1703 Phase 1b/2 Study of Elotuzumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed/refractory Multiple Myeloma." Blood 124, no. 21 (2014).
MLA (9th ed.) CitationRichardson, Paul G., and Marc-Steffen Raab. "Final Results for the 1703 Phase 1b/2 Study of Elotuzumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed/refractory Multiple Myeloma." Blood, vol. 124, no. 21, 2014.
Warning: These citations may not always be 100% accurate.